This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Asia: Oligonucleotide & Peptide Therapeutics Scientific Forum
See You Next Year! 26-28 Feb, 2025
Westin Miyako KyotoKyoto, Japan

Daniel Samson, PhD
Vice President, Head Oligonucleotides at Bachem AG


Daniel Samson, Vice President, Head of Oligonucleotides, leads Bachem's oligonucleotide unit including innovation projects, Research & Development, and manufacturing activities. He holds a PhD in organic chemistry from the University of Konstanz, and an Executive MBA from the International Institute for Management Development (IMD), Lausanne. In previous stages of his career, he was a lab head for CMC development, process optimization, technology transfer, quality by design, and scale-up of synthetic peptide manufacturing procedures and Vice President Peptide Manufacturing.

Agenda Sessions

  • Going Large-scale with Manufacturing of Oligonucleotides